Capricor on Tuesday disclosed that the FDA has indicated that no AdCom is necessary for deramiocel’s Biologics License Application, and an in-person late-cycle review meeting is scheduled for mid-July ...
Travere Therapeutics (NASDAQ:TVTX) climbed ~27% in the premarket on Wednesday after the company said that the FDA has informed it that an advisory committee meeting will not be necessary to review a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback